Inno-Gene SA
WSE:IGN
Balance Sheet
Balance Sheet Decomposition
Inno-Gene SA
Inno-Gene SA
Balance Sheet
Inno-Gene SA
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
4
|
0
|
|
| Cash |
1
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
4
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
|
| Total Receivables |
1
|
1
|
1
|
1
|
2
|
2
|
2
|
5
|
5
|
7
|
|
| Accounts Receivables |
0
|
0
|
1
|
1
|
1
|
1
|
2
|
5
|
3
|
0
|
|
| Other Receivables |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
6
|
|
| Inventory |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Current Assets |
0
|
9
|
1
|
1
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Total Current Assets |
3
|
12
|
4
|
3
|
4
|
3
|
3
|
6
|
12
|
8
|
|
| PP&E Net |
3
|
3
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Intangible Assets |
1
|
0
|
12
|
11
|
10
|
12
|
13
|
12
|
2
|
1
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
|
| Other Long-Term Assets |
4
|
1
|
3
|
4
|
5
|
2
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
10
N/A
|
17
+63%
|
21
+26%
|
20
-8%
|
19
0%
|
18
-6%
|
17
-6%
|
20
+18%
|
15
-25%
|
12
-24%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
2
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
0
|
|
| Accrued Liabilities |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
3
|
2
|
3
|
3
|
3
|
3
|
4
|
5
|
6
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
5
|
11
|
12
|
13
|
13
|
12
|
10
|
10
|
1
|
0
|
|
| Total Liabilities |
10
N/A
|
14
+49%
|
16
+11%
|
17
+7%
|
18
+4%
|
16
-10%
|
15
-7%
|
16
+10%
|
7
-57%
|
3
-57%
|
|
| Equity | |||||||||||
| Common Stock |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
0
|
2
|
5
|
3
|
3
|
3
|
2
|
3
|
8
|
8
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
5
|
5
|
5
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
3
+232%
|
5
+109%
|
3
-52%
|
2
-29%
|
2
+29%
|
2
-3%
|
4
+68%
|
8
+113%
|
9
+5%
|
|
| Total Liabilities & Equity |
10
N/A
|
17
+63%
|
21
+26%
|
20
-8%
|
19
0%
|
18
-6%
|
17
-6%
|
20
+18%
|
15
-25%
|
12
-24%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
5
|
5
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
|